Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology - PubMed (original) (raw)
Review
Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology
R Rupprecht et al. Brain Res Brain Res Rev. 2001 Nov.
Abstract
Besides their binding to cognate intracellular receptors gonadal steroids may also act as functional antagonists at the 5-HT3 receptor. A structure-activity relationship for the actions of a variety of steroids at the 5-HT3 receptor was elaborated that differed considerably from that known for GABA(A) receptors. Steroids appear to interact allosterically with ligand-gated ion channels at the receptor membrane interface. The functional antagonism of gonadal steroids at the 5-HT3 receptor may play a role for the development and course of nausea during pregnancy and of psychiatric disorders. Moreover, we could demonstrate that 3alpha-reduced neuroactive steroids concurrently modulate the GABA(A) receptor and regulate gene expression via the progesterone receptor after intracellular oxidation. Animal studies showed that progesterone is converted rapidly into GABAergic neuroactive steroids in vivo. Progesterone reduces locomotor activity in a dose dependent fashion in male Wister rats. Moreover, progesterone and 3alpha,5alpha-tetrahydroprogesterone produce a benzodiazepine-like sleep EEG profile in rats and humans. In addition, there is a dysequilibrium of such 3alpha-reduced neuroactive steroids during major depression which is corrected by successful treatment with antidepressants. Neuroactive steroids may further be involved in the treatment of depression and anxiety with antidepressants in patients during ethanol withdrawal. First studies in patients with panic disorder suggest that neuroactive steroids may also play a pivotal role in human anxiety. The genomic and non-genomic effects of steroids in the brain contribute to the pathophysiology of psychiatric disorders and the mechanisms of action of antidepressants. Neuroactive steroids affect a broad spectrum of behavioral functions through their unique molecular properties and may constitute a yet unexploited class of drugs.
Similar articles
- Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties.
Rupprecht R. Rupprecht R. Psychoneuroendocrinology. 2003 Feb;28(2):139-68. doi: 10.1016/s0306-4530(02)00064-1. Psychoneuroendocrinology. 2003. PMID: 12510009 Review. - Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives.
Rupprecht R, Holsboer F. Rupprecht R, et al. Trends Neurosci. 1999 Sep;22(9):410-6. doi: 10.1016/s0166-2236(99)01399-5. Trends Neurosci. 1999. PMID: 10441302 Review. - Neuroactive steroids as modulators of depression and anxiety.
Eser D, Romeo E, Baghai TC, di Michele F, Schüle C, Pasini A, Zwanzger P, Padberg F, Rupprecht R. Eser D, et al. Neuroscience. 2006;138(3):1041-8. doi: 10.1016/j.neuroscience.2005.07.007. Epub 2005 Nov 28. Neuroscience. 2006. PMID: 16310959 - Neuroactive steroids in neuropsychopharmacology.
Rupprecht R, Holsboer F. Rupprecht R, et al. Int Rev Neurobiol. 2001;46:461-77. doi: 10.1016/s0074-7742(01)46072-7. Int Rev Neurobiol. 2001. PMID: 11599310 Review. - Neuroactive steroids in depression and anxiety disorders: clinical studies.
Eser D, Schüle C, Baghai TC, Romeo E, Rupprecht R. Eser D, et al. Neuroendocrinology. 2006;84(4):244-54. doi: 10.1159/000097879. Epub 2006 Dec 8. Neuroendocrinology. 2006. PMID: 17159334 Review.
Cited by
- Psychiatric disorders and comorbidity in women with Turner Syndrome: a retrospective national cohort study.
Thunström S, Wide U, Landin-Wilhelmsen K, Berntorp K, Bryman I, Krantz E, Wahlberg J, Ekman B, Isakson M, Karlsson A, Bergström I, Naessén S. Thunström S, et al. Transl Psychiatry. 2024 Sep 4;14(1):355. doi: 10.1038/s41398-024-02937-5. Transl Psychiatry. 2024. PMID: 39227579 Free PMC article. - Emotion-induced brain activation across the menstrual cycle in individuals with premenstrual dysphoric disorder and associations to serum levels of progesterone-derived neurosteroids.
Stiernman L, Dubol M, Comasco E, Sundström-Poromaa I, Boraxbekk CJ, Johansson M, Bixo M. Stiernman L, et al. Transl Psychiatry. 2023 Apr 14;13(1):124. doi: 10.1038/s41398-023-02424-3. Transl Psychiatry. 2023. PMID: 37055419 Free PMC article. - Toward the Development of Personalized Syndrome Discriminant Systems: A Discriminant System for Hypertension with Liver Yang Hyperactivity Syndrome.
Shang GY, Zhang L, Lin L, Jiang HQ, Li C, Jiang F, Qi DM, Li YL, Yang WQ. Shang GY, et al. Evid Based Complement Alternat Med. 2021 Nov 15;2021:4532279. doi: 10.1155/2021/4532279. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34819981 Free PMC article. - Does Stress Trigger Seizures? Evidence from Experimental Models.
Reddy DS, Thompson W, Calderara G. Reddy DS, et al. Curr Top Behav Neurosci. 2022;55:41-64. doi: 10.1007/7854_2020_191. Curr Top Behav Neurosci. 2022. PMID: 33547597 - Physiopathological Role of Neuroactive Steroids in the Peripheral Nervous System.
Falvo E, Diviccaro S, Melcangi RC, Giatti S. Falvo E, et al. Int J Mol Sci. 2020 Nov 26;21(23):9000. doi: 10.3390/ijms21239000. Int J Mol Sci. 2020. PMID: 33256238 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials